Hussein [5] showed that high-levels of IL-6 indicate poor prognosis and the concentration of IL-6 in the serum of breast cancer patients is not only elevated, but increases with the clinical stage of breast cancer. This evidence concerns the gene IL6 and breast carcinoma.